Hydroxyurea for SCA in Africa: no malaria harm

Abstract

In this issue of Blood, Opoka et al report no increased incidence of clinical malaria in a randomized trial of hydroxyurea therapy compared with placebo among young African children with sickle cell anemia (SCA).1.